Pharis Mohideen
2018 - OvaScience
In 2018, Pharis Mohideen earned a total compensation of $919.9K as Chief Medical Officer at OvaScience, a 91% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $106,788 |
|---|---|
| Option Awards | $410,470 |
| Salary | $367,602 |
| Other | $35,021 |
| Total | $919,881 |
Mohideen received $410.5K in option awards, accounting for 45% of the total pay in 2018.
Mohideen also received $106.8K in non-equity incentive plan, $367.6K in salary and $35K in other compensation.
Rankings
In 2018, Pharis Mohideen's compensation ranked 9,598th out of 14,244 executives tracked by ExecPay. In other words, Mohideen earned more than 32.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,598 out of 14,244 | 33rd |
Division Manufacturing | 3,859 out of 5,765 | 33rd |
Major group Chemicals And Allied Products | 1,455 out of 2,128 | 32nd |
Industry group Drugs | 1,225 out of 1,817 | 33rd |
Industry Pharmaceutical Preparations | 944 out of 1,391 | 32nd |
Source: SEC filing on April 29, 2019.
Mohideen's colleagues
We found four more compensation records of executives who worked with Pharis Mohideen at OvaScience in 2018.